PMID: 22359953Mar 1, 2012Paper

Genetic manipulation and studying of differentiation properties of rat induced pluripotent stem cells

Tsitologiia
M A LiskovykhA N Tomilin

Abstract

Induced pluripotent stem (iPS) cells are derived from somatic cells reprogrammed to the pluripotent state by the induced expression of defined transcription factors, achieved for the first time by the seminal work of Takahashi and Yamanaka. This new type of pluripotent cells has offered new exciting options in regenerative medicine allowing the replacement of cells and organs with the patient's own cells thereby avoiding immunological complications. In order to develop such technologies in approved animal models, iPS cells were also generated from rodents. Of course, the most important model for studying of different diseases is rat. In this study, we present a method suitable for rat iPS cells genetic modification by stable transfection and show necessary conditions for the first stages of direct differentiation.

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Related Papers

Experimental Biology and Medicine
Jesse L Cox, Angie Rizzino
The International Journal of Biochemistry & Cell Biology
Alejandra M VitaleAlan Mackay-Sim
Rinshō shinkeigaku = Clinical neurology
Daisuke ItoNorihiro Suzuki
© 2022 Meta ULC. All rights reserved